Table 1.
Antibiotic | Dataset | tau (95% CI) | P | |
Penicillin | Massachusetts | 0.39 | 0.34 (− 0.04, 0.61) | 0.045 |
Penicillin | Malawi | 0.21 | 0.49 (− 0.09, 0.79) | 0.035 |
Penicillin | Maela | 0.49 | 0.46 (0.27, 0.58) | 8.6 10-6 |
Penicillin | Combined | — | — | 2.4 10-6 |
Co-trimoxazole | Malawi | 0.46 | − 0.14 (− 0.62, 0.41) | 0.70 |
Co-trimoxazole | Maela | 0.81 | 0.22 (0.03, 0.39) | 0.012 |
Co-trimoxazole | Combined | — | — | 0.049 |
Trimethoprim | Massachusetts | 0.14 | 0.38 (0.01, 0.64) | 0.027 |
Erythromycin | Massachusetts | 0.19 | 0.34 (− 0.04, 0.61) | 0.045 |
Ceftriaxone | Massachusetts | 0.13 | 0.35 (− 0.03, 0.62) | 0.047 |
Number of isolates and serotypes for which carriage duration could be calculated: Massachusetts, 180 and 19; Malawi, 300 (Materials and Methods) and 9; and Maela, 2,923 and 51. P values are one-tailed, which is why 95% CIs sometimes overlap zero for P < 0.05. Combined P values were calculated using Fisher’s method for all three datasets for penicillin and Malawi and Maela for co-trimoxazole (we treated trimethoprim and co-trimoxazole as different drugs). Bold P values are below 0.05. Values of tau for antibiotics in the Massachusetts dataset are similar because there is a strong association between resistance to different antibiotics (e.g., odds ratio for penicillin and erythromycin nonsensitivity: 10; 95% CI: 6–21).